Common Contracts
4 similar Underwriting Agreement contracts by Movano Inc., Eton Pharmaceuticals, Inc., TFF Pharmaceuticals, Inc.
MOVANO INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 17th, 2021 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
The undersigned, Movano Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), a company formed under the laws of Delaware, hereby confirms its agreement with National Securities Corporation (hereinafter referred to as the “Representative”), a Washington corporation, and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
MOVANO INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 10th, 2021 • Movano Inc. • Electromedical & electrotherapeutic apparatus • New York
The undersigned, Movano Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), a company formed under the laws of Delaware, hereby confirms its agreement with National Securities Corporation (hereinafter referred to as the “Representative”), a Washington corporation, and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
TFF PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 27th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, TFF Pharmaceuticals, Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), a company formed under the laws of Delaware, hereby confirms its agreement with National Securities Corporation (hereinafter referred to as the “Representative”), a Washington corporation, and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
ETON PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 31st, 2018 • Eton Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
The undersigned, Eton Pharmaceuticals, Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), a company formed under the laws of Delaware, hereby confirms its agreement with National Securities Corporation (hereinafter referred to as the “Representative”), a Washington corporation, and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
